Alloy Ventures is an early-stage venture capital firm based in Palo Alto, California, with over $1 billion under management. Founded in 1996, the firm focuses on investing in the next generation of groundbreaking companies in Information Technology, Life Sciences, and Cleantech sectors. Over the past three decades, Alloy Ventures has leveraged the operational experience, extensive networks, and forward-thinking vision of its partners to help start and build over 200 market-leading companies in fields such as software, semiconductors, mobile, medical devices, diagnostics, and laboratory instrumentation.

Notable past investments include Amgen, Applied Biosystems, Aspect Communications, CV Therapeutics, IDEC Pharmaceuticals, Nuance Communications, Octel, PMC-Sierra, Red Brick Systems, Remedy, and Verity. Current portfolio companies include Agari, Optimedica, Pacific Biosciences, Restoration Robotics, and Teradici, which are poised to become the next global leaders.